FG
GSK icon

Fairman Group’s GSK GSK Stock Holding History

Fairman Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11K Hold
20
– – ﹤0.01% 294
2025
Q4 		$989 Hold
20
– – ﹤0.01% 302
2025
Q3 		$872 Hold
20
– – ﹤0.01% 245
2025
Q2 		$777 Hold
20
– – ﹤0.01% 228
2025
Q1 		$3.42K Sell
20
-80
-80% -$2.93K ﹤0.01% 184
2024
Q4 		$3.42K Hold
100
– – ﹤0.01% 201
2024
Q3 		$4.13K Hold
100
– – ﹤0.01% 215
2024
Q2 		$3.89K Hold
100
– – ﹤0.01% 215
2024
Q1 		$4.33K Hold
100
– – ﹤0.01% 203
2023
Q4 		$3.74K Buy
+100
New +$3.59K ﹤0.01% 212

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fairman Group's GSK Position: Q1 2026 in Review

Fairman Group held its GSK (GSK) position steady in Q1 2026 at 20 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Fairman Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.33K in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Fairman Group held 20 shares of GSK worth $1.11K as of Q1 2026.
  • Fairman Group left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of Fairman Group's portfolio in Q1 2026, its #294 holding.
  • Fairman Group first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • Fairman Group's GSK position peaked at $4.33K in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Fairman Group's 13F filing for Q1 2026, filed 23 Apr 2026.